| 0 |
EOSINOPHIL COUNT NORMAL |
1 |
0.0714 |
| 1 |
PHOSPHOLIPIDOSIS |
2 |
0.0202 |
| 2 |
HOME CARE |
1 |
0.0156 |
| 3 |
MESENTERIC HAEMORRHAGE |
1 |
0.0116 |
| 4 |
SOMATIC DYSFUNCTION |
1 |
0.0111 |
| 5 |
AMINO ACID LEVEL ABNORMAL |
1 |
0.0103 |
| 6 |
ANTACID THERAPY |
1 |
0.0077 |
| 7 |
VENTRICULAR ASYSTOLE |
1 |
0.0057 |
| 8 |
MUSCULOSKELETAL TOXICITY |
1 |
0.0054 |
| 9 |
CYSTITIS RADIATION |
1 |
0.0052 |
| 10 |
SLEEP DISORDER THERAPY |
1 |
0.0051 |
| 11 |
MALIGNANT MELANOMA STAGE 0 |
1 |
0.0048 |
| 12 |
CONGENITAL HIATUS HERNIA |
1 |
0.0044 |
| 13 |
PNEUMOTHORAX TRAUMATIC |
1 |
0.0041 |
| 14 |
BACTEROIDES INFECTION |
1 |
0.0038 |
| 15 |
ANTICOAGULANT THERAPY |
1 |
0.0035 |
| 16 |
ANALGESIC THERAPY |
1 |
0.0031 |
| 17 |
CANDIDA PNEUMONIA |
1 |
0.0031 |
| 18 |
DRUG THERAPY |
1 |
0.0029 |
| 19 |
AMYOTROPHY |
1 |
0.0026 |
| 20 |
APPENDICOLITH |
1 |
0.0026 |
| 21 |
URETHRAL OBSTRUCTION |
1 |
0.0025 |
| 22 |
RED BLOOD CELL TRANSFUSION |
1 |
0.0024 |
| 23 |
SINUS RHYTHM |
1 |
0.0023 |
| 24 |
MITOCHONDRIAL CYTOPATHY |
1 |
0.0023 |
| 25 |
BONE DEMINERALISATION |
2 |
0.0019 |
| 26 |
POSTOPERATIVE ILEUS |
1 |
0.0018 |
| 27 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
1 |
0.0011 |
| 28 |
TOOTH EROSION |
1 |
0.0008 |
| 29 |
PLATELET TRANSFUSION |
1 |
0.0008 |
| 30 |
ECHOCARDIOGRAM ABNORMAL |
1 |
0.0007 |
| 31 |
ANTICONVULSANT DRUG LEVEL DECREASED |
1 |
0.0007 |
| 32 |
TONIC CONVULSION |
1 |
0.0007 |
| 33 |
TOTAL LUNG CAPACITY DECREASED |
1 |
0.0006 |
| 34 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 35 |
APLASTIC ANAEMIA |
3 |
0.0006 |
| 36 |
AORTIC STENOSIS |
2 |
0.0006 |
| 37 |
UNDERWEIGHT |
1 |
0.0005 |
| 38 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 39 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 40 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 41 |
PERIARTHRITIS |
1 |
0.0004 |
| 42 |
ORAL PRURITUS |
1 |
0.0004 |
| 43 |
METASTATIC MALIGNANT MELANOMA |
1 |
0.0004 |
| 44 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 45 |
VOLVULUS |
1 |
0.0004 |
| 46 |
CARDIOMYOPATHY |
6 |
0.0004 |
| 47 |
LUNG OPACITY |
1 |
0.0004 |
| 48 |
BLOOD PHOSPHORUS INCREASED |
1 |
0.0004 |
| 49 |
PLEURITIC PAIN |
1 |
0.0004 |
| 50 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 51 |
PHARMACEUTICAL PRODUCT COMPLAINT |
9 |
0.0003 |
| 52 |
MASTICATION DISORDER |
1 |
0.0003 |
| 53 |
EOSINOPHILIC PNEUMONIA |
1 |
0.0003 |
| 54 |
VENTRICULAR ARRHYTHMIA |
1 |
0.0003 |
| 55 |
MYASTHENIA GRAVIS |
2 |
0.0002 |
| 56 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
1 |
0.0002 |
| 57 |
ABSCESS LIMB |
1 |
0.0002 |
| 58 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 59 |
IRON DEFICIENCY |
1 |
0.0002 |
| 60 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 61 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 62 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 63 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 64 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 65 |
CACHEXIA |
1 |
0.0002 |
| 66 |
BENIGN PROSTATIC HYPERPLASIA |
1 |
0.0002 |
| 67 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 68 |
VENTRICULAR EXTRASYSTOLES |
2 |
0.0002 |
| 69 |
CLOSTRIDIUM DIFFICILE COLITIS |
2 |
0.0002 |
| 70 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 71 |
ASPIRATION |
2 |
0.0002 |
| 72 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 73 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 74 |
RALES |
1 |
0.0002 |
| 75 |
OLIGURIA |
1 |
0.0002 |
| 76 |
SOMNAMBULISM |
1 |
0.0002 |
| 77 |
MENINGITIS |
1 |
0.0001 |
| 78 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 79 |
QUALITY OF LIFE DECREASED |
2 |
0.0001 |
| 80 |
BRONCHIECTASIS |
1 |
0.0001 |
| 81 |
BLOOD TEST ABNORMAL |
2 |
0.0001 |
| 82 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 83 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 84 |
TROPONIN INCREASED |
1 |
0.0001 |
| 85 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 86 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 87 |
CONCUSSION |
1 |
0.0001 |
| 88 |
PELVIC FRACTURE |
1 |
0.0001 |
| 89 |
TORSADE DE POINTES |
1 |
0.0001 |
| 90 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 91 |
SUBSTANCE ABUSE |
1 |
0.0001 |
| 92 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 93 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 94 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 95 |
MYOPATHY |
1 |
0.0001 |
| 96 |
MUCOSAL INFLAMMATION |
3 |
0.0001 |
| 97 |
ANHEDONIA |
3 |
0.0001 |
| 98 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 99 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 100 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
2 |
0.0001 |
| 101 |
MYOSITIS |
1 |
0.0001 |
| 102 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 103 |
APPENDICITIS |
1 |
0.0001 |
| 104 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 105 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 106 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 107 |
EYELID PTOSIS |
1 |
0.0001 |
| 108 |
OSTEOPOROSIS |
4 |
0.0001 |
| 109 |
TRANSFUSION |
1 |
0.0001 |
| 110 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 111 |
JOINT INJURY |
2 |
0.0001 |
| 112 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 113 |
DENTAL CARIES |
1 |
0.0001 |
| 114 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 115 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 116 |
MICTURITION URGENCY |
1 |
0.0001 |
| 117 |
MYOCARDITIS |
1 |
0.0001 |
| 118 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 119 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 120 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 121 |
INTERCEPTED PRODUCT PREPARATION ERROR |
1 |
0.0001 |
| 122 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 123 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 124 |
DIALYSIS |
1 |
0.0001 |
| 125 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 126 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 127 |
PULMONARY MASS |
1 |
0.0001 |
| 128 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 129 |
OSTEOPENIA |
1 |
0.0001 |
| 130 |
DRUG-INDUCED LIVER INJURY |
2 |
0.0001 |
| 131 |
ULCER |
1 |
0.0001 |
| 132 |
CARDIAC FAILURE CONGESTIVE |
5 |
0.0001 |
| 133 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 134 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 135 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 136 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 137 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 138 |
BRADYCARDIA |
3 |
0.0001 |
| 139 |
GOUT |
1 |
0.0001 |
| 140 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 141 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 142 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 143 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 144 |
COLITIS |
2 |
0.0001 |
| 145 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 146 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 147 |
HAEMORRHOIDS |
1 |
0.0001 |
| 148 |
FEEDING DISORDER |
1 |
0.0000 |
| 149 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 150 |
RIB FRACTURE |
1 |
0.0000 |
| 151 |
TOOTH LOSS |
1 |
0.0000 |
| 152 |
EATING DISORDER |
1 |
0.0000 |
| 153 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 154 |
SKIN CANCER |
1 |
0.0000 |
| 155 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 156 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 157 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 158 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 159 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 160 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 161 |
NEURALGIA |
1 |
0.0000 |
| 162 |
DYSGEUSIA |
3 |
0.0000 |
| 163 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 164 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 165 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 166 |
SEDATION |
1 |
0.0000 |
| 167 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 168 |
HAEMOPTYSIS |
1 |
0.0000 |
| 169 |
HYPONATRAEMIA |
2 |
0.0000 |
| 170 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
1 |
0.0000 |
| 171 |
FLATULENCE |
2 |
0.0000 |
| 172 |
SEIZURE |
4 |
0.0000 |
| 173 |
DYSSTASIA |
1 |
0.0000 |
| 174 |
ASCITES |
1 |
0.0000 |
| 175 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 176 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 177 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 178 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 179 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 180 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 181 |
OSTEONECROSIS |
1 |
0.0000 |
| 182 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 183 |
GAIT INABILITY |
1 |
0.0000 |
| 184 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 185 |
HAEMATURIA |
1 |
0.0000 |
| 186 |
DELIRIUM |
1 |
0.0000 |
| 187 |
HYPOXIA |
1 |
0.0000 |
| 188 |
SLEEP DISORDER |
2 |
0.0000 |
| 189 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 190 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 191 |
PANIC ATTACK |
1 |
0.0000 |
| 192 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 193 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 194 |
SEPSIS |
3 |
0.0000 |
| 195 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 196 |
EMOTIONAL DISTRESS |
3 |
0.0000 |
| 197 |
DYSKINESIA |
1 |
0.0000 |
| 198 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 199 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 200 |
HYPOACUSIS |
1 |
0.0000 |
| 201 |
MENTAL DISORDER |
1 |
0.0000 |
| 202 |
CONSTIPATION |
5 |
0.0000 |
| 203 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 204 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 205 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 206 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 207 |
ADVERSE EVENT |
2 |
0.0000 |
| 208 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 209 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 210 |
COMA |
1 |
0.0000 |
| 211 |
LUNG DISORDER |
1 |
0.0000 |
| 212 |
ACUTE KIDNEY INJURY |
3 |
0.0000 |
| 213 |
THERAPY CESSATION |
1 |
0.0000 |
| 214 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 215 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 216 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 217 |
OVERDOSE |
4 |
0.0000 |
| 218 |
TREATMENT NONCOMPLIANCE |
1 |
0.0000 |
| 219 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 220 |
BLISTER |
1 |
0.0000 |
| 221 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 222 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 223 |
CONVULSION |
1 |
0.0000 |
| 224 |
PALPITATIONS |
2 |
0.0000 |
| 225 |
BONE PAIN |
1 |
0.0000 |
| 226 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 227 |
WHEEZING |
1 |
0.0000 |
| 228 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 229 |
AMNESIA |
1 |
0.0000 |
| 230 |
RENAL FAILURE |
2 |
0.0000 |
| 231 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 232 |
INJURY |
1 |
0.0000 |
| 233 |
HYPERTENSION |
3 |
0.0000 |
| 234 |
MOBILITY DECREASED |
1 |
0.0000 |
| 235 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 236 |
ASTHENIA |
5 |
0.0000 |
| 237 |
DIABETES MELLITUS |
1 |
0.0000 |
| 238 |
ABDOMINAL PAIN |
3 |
0.0000 |
| 239 |
VOMITING |
6 |
0.0000 |
| 240 |
DRUG INTERACTION |
2 |
0.0000 |
| 241 |
OFF LABEL USE |
11 |
0.0000 |
| 242 |
CARDIAC FAILURE |
1 |
0.0000 |
| 243 |
THROMBOSIS |
1 |
0.0000 |
| 244 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 245 |
DRY MOUTH |
1 |
0.0000 |
| 246 |
CARDIAC ARREST |
1 |
0.0000 |
| 247 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 248 |
TREATMENT FAILURE |
1 |
0.0000 |
| 249 |
DRUG ABUSE |
1 |
0.0000 |
| 250 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 251 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 252 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 253 |
BALANCE DISORDER |
1 |
0.0000 |
| 254 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 255 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 256 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 257 |
DEVICE ISSUE |
1 |
0.0000 |
| 258 |
DIARRHOEA |
7 |
0.0000 |
| 259 |
CHEST PAIN |
2 |
0.0000 |
| 260 |
SWELLING |
1 |
0.0000 |
| 261 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 262 |
ANXIETY |
3 |
0.0000 |
| 263 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 264 |
ANAEMIA |
2 |
0.0000 |
| 265 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 266 |
SYNCOPE |
1 |
0.0000 |
| 267 |
SOMNOLENCE |
2 |
0.0000 |
| 268 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 269 |
PAIN |
6 |
0.0000 |
| 270 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 271 |
ILLNESS |
1 |
0.0000 |
| 272 |
ASTHMA |
1 |
0.0000 |
| 273 |
NAUSEA |
7 |
0.0000 |
| 274 |
PYREXIA |
3 |
0.0000 |
| 275 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 276 |
DRUG INEFFECTIVE |
11 |
0.0000 |
| 277 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 278 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 279 |
HEADACHE |
5 |
0.0000 |
| 280 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 281 |
HYPERHIDROSIS |
1 |
0.0000 |
| 282 |
DEHYDRATION |
1 |
0.0000 |
| 283 |
NEUTROPENIA |
1 |
0.0000 |
| 284 |
VISION BLURRED |
1 |
0.0000 |
| 285 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 286 |
HYPOAESTHESIA |
1 |
0.0000 |
| 287 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 288 |
HOSPITALISATION |
1 |
0.0000 |
| 289 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 290 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 291 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 292 |
TREMOR |
1 |
0.0000 |
| 293 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 294 |
COVID-19 |
1 |
0.0000 |
| 295 |
MUSCLE SPASMS |
1 |
0.0000 |
| 296 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 297 |
DYSPNOEA |
3 |
0.0000 |
| 298 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 299 |
FATIGUE |
4 |
0.0000 |
| 300 |
HYPOTENSION |
1 |
0.0000 |
| 301 |
DEATH |
4 |
0.0000 |
| 302 |
RASH |
2 |
0.0000 |
| 303 |
MALAISE |
2 |
0.0000 |
| 304 |
DEPRESSION |
1 |
0.0000 |
| 305 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 306 |
DECREASED APPETITE |
1 |
0.0000 |
| 307 |
BACK PAIN |
1 |
0.0000 |
| 308 |
WEIGHT DECREASED |
1 |
0.0000 |
| 309 |
COUGH |
1 |
0.0000 |
| 310 |
PNEUMONIA |
1 |
0.0000 |
| 311 |
FALL |
1 |
0.0000 |
| 312 |
ARTHRALGIA |
1 |
0.0000 |
| 313 |
DIZZINESS |
1 |
0.0000 |